<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ishmael L</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NCATS NIH HHS</funding><funding>American Academy of Allergy Asthma and Immunology</funding><funding>NIAID NIH HHS</funding><funding>NIEHS NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>American Lung Association</funding><funding>Patient-Centered Outcomes Research Institute</funding><funding>Bristol Myers Squibb Foundation</funding><pagination>408-417</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10922293</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>153(2)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Black adults are disproportionately affected by asthma and are often considered a homogeneous group in research studies despite cultural and ancestral differences.&lt;h4>Objective&lt;/h4>We sought to determine if asthma morbidity differs across adults in Black ethnic subgroups.&lt;h4>Methods&lt;/h4>Adults with moderate-severe asthma were recruited across the continental United States and Puerto Rico for the PREPARE (PeRson EmPowered Asthma RElief) trial. Using self-identifications, we categorized multiethnic Black (ME/B) participants (n = 226) as Black Latinx participants (n = 146) or Caribbean, continental African, or other Black participants (n = 80). African American (AA/B) participants (n = 518) were categorized as Black participants who identified their ethnicity as being American. Baseline characteristics and retrospective asthma morbidity measures (self-reported exacerbations requiring systemic corticosteroids [SCs], emergency department/urgent care [ED/UC] visits, hospitalizations) were compared across subgroups using multivariable regression.&lt;h4>Results&lt;/h4>Compared with AA/B participants, ME/B participants were more likely to be younger, residing in the US Northeast, and Spanish speaking and to have lower body mass index, health literacy, and &lt;1 comorbidity, but higher blood eosinophil counts. In a multivariable analysis, ME/B participants were significantly more likely to have ED/UC visits (incidence rate ratio [IRR] = 1.34, 95% CI = 1.04-1.72) and SC use (IRR = 1.27, 95% CI = 1.00-1.62) for asthma than AA/B participants. Of the ME/B subgroups, Puerto Rican Black Latinx participants (n = 120) were significantly more likely to have ED/UC visits (IRR = 1.64, 95% CI = 1.22-2.21) and SC use for asthma (IRR = 1.43, 95% CI = 1.06-1.92) than AA/B participants. There were no significant differences in hospitalizations for asthma among subgroups.&lt;h4>Conclusions&lt;/h4>ME/B adults, specifically Puerto Rican Black Latinx adults, have higher risk of ED/UC visits and SC use for asthma than other Black subgroups.</pubmed_abstract><journal>The Journal of allergy and clinical immunology</journal><pubmed_title>Asthma morbidity measures across Black ethnic subgroups.</pubmed_title><pmcid>PMC10922293</pmcid><funding_grant_id>K23AI125785</funding_grant_id><funding_grant_id>R21 HL172124</funding_grant_id><funding_grant_id>PCS-1504-30283</funding_grant_id><funding_grant_id>P30 ES013508</funding_grant_id><funding_grant_id>UM1 TR004528</funding_grant_id><funding_grant_id>K01 HL159043</funding_grant_id><funding_grant_id>AI-835475</funding_grant_id><funding_grant_id>K23 AI125785</funding_grant_id><pubmed_authors>Calderon-Candelario R</pubmed_authors><pubmed_authors>Casale T</pubmed_authors><pubmed_authors>Yawn B</pubmed_authors><pubmed_authors>Mosnaim G</pubmed_authors><pubmed_authors>Carroll JK</pubmed_authors><pubmed_authors>Merriman C</pubmed_authors><pubmed_authors>Shenoy K</pubmed_authors><pubmed_authors>Riley I</pubmed_authors><pubmed_authors>Maher N</pubmed_authors><pubmed_authors>Coyne-Beasley T</pubmed_authors><pubmed_authors>Cohen R</pubmed_authors><pubmed_authors>Kaelber DC</pubmed_authors><pubmed_authors>Cui J</pubmed_authors><pubmed_authors>Hernandez P</pubmed_authors><pubmed_authors>Pinto-Plata V</pubmed_authors><pubmed_authors>Wisnivesky J</pubmed_authors><pubmed_authors>Busse PJ</pubmed_authors><pubmed_authors>Nazario S</pubmed_authors><pubmed_authors>Cardet JC</pubmed_authors><pubmed_authors>Celedon JC</pubmed_authors><pubmed_authors>Ericson B</pubmed_authors><pubmed_authors>Israel E</pubmed_authors><pubmed_authors>Apter A</pubmed_authors><pubmed_authors>Ishmael L</pubmed_authors><pubmed_authors>Phipatanakul W</pubmed_authors></additional><is_claimable>false</is_claimable><name>Asthma morbidity measures across Black ethnic subgroups.</name><description>&lt;h4>Background&lt;/h4>Black adults are disproportionately affected by asthma and are often considered a homogeneous group in research studies despite cultural and ancestral differences.&lt;h4>Objective&lt;/h4>We sought to determine if asthma morbidity differs across adults in Black ethnic subgroups.&lt;h4>Methods&lt;/h4>Adults with moderate-severe asthma were recruited across the continental United States and Puerto Rico for the PREPARE (PeRson EmPowered Asthma RElief) trial. Using self-identifications, we categorized multiethnic Black (ME/B) participants (n = 226) as Black Latinx participants (n = 146) or Caribbean, continental African, or other Black participants (n = 80). African American (AA/B) participants (n = 518) were categorized as Black participants who identified their ethnicity as being American. Baseline characteristics and retrospective asthma morbidity measures (self-reported exacerbations requiring systemic corticosteroids [SCs], emergency department/urgent care [ED/UC] visits, hospitalizations) were compared across subgroups using multivariable regression.&lt;h4>Results&lt;/h4>Compared with AA/B participants, ME/B participants were more likely to be younger, residing in the US Northeast, and Spanish speaking and to have lower body mass index, health literacy, and &lt;1 comorbidity, but higher blood eosinophil counts. In a multivariable analysis, ME/B participants were significantly more likely to have ED/UC visits (incidence rate ratio [IRR] = 1.34, 95% CI = 1.04-1.72) and SC use (IRR = 1.27, 95% CI = 1.00-1.62) for asthma than AA/B participants. Of the ME/B subgroups, Puerto Rican Black Latinx participants (n = 120) were significantly more likely to have ED/UC visits (IRR = 1.64, 95% CI = 1.22-2.21) and SC use for asthma (IRR = 1.43, 95% CI = 1.06-1.92) than AA/B participants. There were no significant differences in hospitalizations for asthma among subgroups.&lt;h4>Conclusions&lt;/h4>ME/B adults, specifically Puerto Rican Black Latinx adults, have higher risk of ED/UC visits and SC use for asthma than other Black subgroups.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-06-01T14:39:47.65Z</modification><creation>2025-04-03T23:22:14.52Z</creation></dates><accession>S-EPMC10922293</accession><cross_references><pubmed>38000696</pubmed><doi>10.1016/j.jaci.2023.10.028</doi></cross_references></HashMap>